(phosphoserine 217/221)
Produced in Rabbit, Affinity Isolated Antibody
Product Number M 7683
Product Description
Anti-phospho-MAP Kinase Kinase 1/2 (MEK 1/2)
(phosphoserine 217/221) is developed
E-mail address: jeonghd@pknu.ac.kr (H.D. Jeong).
www.elsevier.com/locate/aqua-online
Aquaculture 217 (2003) 11–21
originated from a very limited environmental or biological source and was not
E-mail address: jeonghd@pknu.ac.kr (H.D. Jeong).
www.elsevier.com/locate/aqua-online
Aquaculture 217 (2003) 11–21
originated from a very limited environmental or biological source and was not
203-217/6, purified from hybridoma cell culture
Product Number A4475
Product Description
Anti-Annexin VII antibody, Mouse monoclonal (mouse
IgG1 isotype) is derived from the 203-217/6 hybridoma
synthetic peptide correspon-
ding to the C-terminal region of human, rat and mouse
Grb2 (a.a. 200-217) conjugated to KLH. The isotype is
determined using Sigma ImmunoTypeTM Kit (Sigma
ISO-1) and by a
Sample: Sildenafil Citrate RS 28ppm, Sildenafil Related compound A 28ppm in
diluent
Pressure Drop: 217 Bar (3146.5 psi)
120
40
60
80
100
In
te
ns
it
y
(m
V)
International
Union of Pharmacology. XXVIII. Proteinase-
Activated Receptors. Pharmacol. Rev., 54, 213-217
(2002).
2. Bono, F., et al., Induction of vascular smooth
muscle cell growth by selective activation
a label for the 5-HT2 receptor in rat frontal cortex." Pharmacol. Biochem. Behav.
35, 211-217 (1990).
3. Glennon, R.A., Titeler, M., Lyon, R.A. "A preliminary investigation of the psychoactive agent
have a
neutral pH.3
Storage/Stability
Solutions should be protected from light.
References
1. Handbook of Clinical Veterinary Pharmacology, D.
W. Upson ed., 2nd ed., p. 217 (1985).
2. Martindale
199 (1993).
3. Sala, M., Braida, D., Calcuterra, P., Leone, M.P., Guri, E. “Dose-dependent conditioned place preference produced by
etonitazene and morphine.” Eur. J. Pharmacol. 217(1), 37 (1992).
Pharmacol. Rev., 54, 213-217
(2002).
2. Nystedt, S. et al., Molecular cloning of a potential
proteinase activated receptor. Proc. Natl. Acad. Sci.
USA, 91, 9208-9212 (1994).
3. Kawao, N. et al., Protease-activated
Oxford University Press (New York, NY: 1986), p. 324-325
3. B. Storrie, E.A. Madden, Buffer for assay of horseradish peroxidase Meth. Enzymol. 182, 217
(1990)
4. The Merck Index, 13th ed., Entry# 4935
Oxford University Press (New York, NY: 1986), p. 324-325
3. B. Storrie, E.A. Madden, Buffer for assay of horseradish peroxidase Meth. Enzymol. 182, 217
(1990)
4. The Merck Index, 13th ed., Entry# 4935
. and Ikenaka, T. (1987) J. Biochem., 101, 217.
2) Shimada, Y., Sugihara, A., Tominaga, Y., Iizumi, T. and Tsunasawa, S. (1989) J. Biochem., 106,
383.
3) Tsunasawa, S., Nakura, S. Tanigawa, T. and
International
Union of Pharmacology. XXVIII. Proteinase-
activated receptors. Pharmacol. Rev., 54, 203-217
(2002).
3. Hollenberg, M.D., and Saifeddine, M., Proteinase-
activated receptor 4 (PAR4): activation
d217dat.doc
ANTI-DOPAMINE-β-HYDROXYLASE (N-TERMINAL)
ANTIBODY, HUMAN
Product Number D-217
Product Description
Anti-Dopamine-β-Hydroxylase (N-terminal) was
developed in sheep using a